Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the NK Cells industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Affimed NV (Netherlands)
NantKwest Inc (USA)
Bristol-Myers Squibb (USA)
Chipscreen Biosciences (China)
Sorrento Therapeutics Inc (USA)
Takeda Pharmaceutical (Japan)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
NKT Therapeutics (USA)
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
Application:
Cancer
Cardiovascular Diseases
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 NK Cells Industry Overview
-
1.1.1 NK Cells Market Scope and Market Segments
-
1.1.2 NK Cells Industry Characteristics
-
1.1.3 Global and China NK Cells Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China NK Cells Production Value and Growth Rate (2017-2028)
-
1.2 Global NK Cells Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Mogamulizumab
-
1.2.2 Lorvotuzumab Mertansine
-
1.2.3 Others
-
1.3 Global NK Cells Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Cancer
-
1.3.2 Cardiovascular Diseases
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America NK Cells Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe NK Cells Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC NK Cells Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa NK Cells Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global NK Cells Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global NK Cells Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China NK Cells Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China NK Cells Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global NK Cells Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 NK Cells Industry Porter's Five Forces Model Analysis
-
2.2.3 NK Cells Industry PEST Analysis
-
2.3 NK Cells Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 NK Cells Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on NK Cells Industry
Chapter 3 Global and China NK Cells Market, by Manufacturer
-
3.1 Global and China NK Cells Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China NK Cells Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China NK Cells Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China NK Cells Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China NK Cells Market Top 3 Players
Chapter 4 Global and China NK Cells Market, by Type (2017-2028)
-
4.1 NK Cells Market Trend, by Type
-
4.2 Global NK Cells Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global NK Cells Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global NK Cells Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global NK Cells Price Trend, by Type (2017-2028)
-
4.3 China NK Cells Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China NK Cells Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China NK Cells Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China NK Cells Price Trend, by Type (2017-2028)
Chapter 5 Global and China NK Cells Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global NK Cells Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global NK Cells Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global NK Cells Sales Value and Market Share, by Application (2017-2028)
-
5.3 China NK Cells Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China NK Cells Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China NK Cells Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global NK Cells Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China NK Cells Production, Import, Consumption and Export (2017-2022)
-
6.2 North America NK Cells Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe NK Cells Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC NK Cells Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa NK Cells Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America NK Cells Market Analysis
-
7.1 North America NK Cells Market, by Type
-
7.2 North America NK Cells Market, by Application
-
7.3 North America NK Cells Market Analysis and Forecast, by Country
-
7.3.1 United States NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe NK Cells Market Analysis
-
8.1 Europe NK Cells Market, by Type
-
8.2 Europe NK Cells Market, by Application
-
8.3 Europe NK Cells Market Analysis and Forecast, by Country
-
8.3.1 Germany NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC NK Cells Market Analysis
-
9.1 APAC NK Cells Market, by Type
-
9.2 APAC NK Cells Market, by Application
-
9.3 APAC NK Cells Market Analysis and Forecast, by Country
-
9.3.1 China NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa NK Cells Market Analysis
-
10.1 Latin America, Middle East and Africa NK Cells Market, by Type
-
10.2 Latin America, Middle East and Africa NK Cells Market, by Application
-
10.3 Latin America, Middle East and Africa NK Cells Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina NK Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China NK Cells Company Profiles
-
11.1 Affimed NV (Netherlands)
-
11.1.1 Affimed NV (Netherlands) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Affimed NV (Netherlands) NK Cells Product Profiles, Application and Specification
-
11.1.3 Affimed NV (Netherlands) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 NantKwest Inc (USA)
-
11.2.1 NantKwest Inc (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 NantKwest Inc (USA) NK Cells Product Profiles, Application and Specification
-
11.2.3 NantKwest Inc (USA) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Bristol-Myers Squibb (USA)
-
11.3.1 Bristol-Myers Squibb (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Bristol-Myers Squibb (USA) NK Cells Product Profiles, Application and Specification
-
11.3.3 Bristol-Myers Squibb (USA) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Chipscreen Biosciences (China)
-
11.4.1 Chipscreen Biosciences (China) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Chipscreen Biosciences (China) NK Cells Product Profiles, Application and Specification
-
11.4.3 Chipscreen Biosciences (China) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Sorrento Therapeutics Inc (USA)
-
11.5.1 Sorrento Therapeutics Inc (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Sorrento Therapeutics Inc (USA) NK Cells Product Profiles, Application and Specification
-
11.5.3 Sorrento Therapeutics Inc (USA) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Takeda Pharmaceutical (Japan)
-
11.6.1 Takeda Pharmaceutical (Japan) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Takeda Pharmaceutical (Japan) NK Cells Product Profiles, Application and Specification
-
11.6.3 Takeda Pharmaceutical (Japan) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Altor BioScience Corporation (USA)
-
11.7.1 Altor BioScience Corporation (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Altor BioScience Corporation (USA) NK Cells Product Profiles, Application and Specification
-
11.7.3 Altor BioScience Corporation (USA) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Innate Pharma SA (France)
-
11.8.1 Innate Pharma SA (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Innate Pharma SA (France) NK Cells Product Profiles, Application and Specification
-
11.8.3 Innate Pharma SA (France) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 NKT Therapeutics (USA)
-
11.9.1 NKT Therapeutics (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 NKT Therapeutics (USA) NK Cells Product Profiles, Application and Specification
-
11.9.3 NKT Therapeutics (USA) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 NK Cells Industry Investment Prospect and Risk Assessment
-
12.1 NK Cells Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 NK Cells Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure China NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Global NK Cells Production Value and Growth Rate (2017-2028)
-
Figure China NK Cells Production Value and Growth Rate (2017-2028)
-
Figure Global NK Cells Market Size and Growth Rate of Mogamulizumab (2017-2028)
-
Figure Global NK Cells Market Size and Growth Rate of Lorvotuzumab Mertansine (2017-2028)
-
Figure Global NK Cells Market Size and Growth Rate of Others (2017-2028)
-
Figure Global NK Cells Market Size and Growth Rate of Cancer (2017-2028)
-
Figure Global NK Cells Market Size and Growth Rate of Cardiovascular Diseases (2017-2028)
-
Figure Global NK Cells Market Size and Growth Rate of Others (2017-2028)
-
Figure North America NK Cells Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe NK Cells Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC NK Cells Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa NK Cells Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global NK Cells Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China NK Cells Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China NK Cells Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China NK Cells Sales Value, by Manufacturer (2021&2022)
-
Table Global and China NK Cells Market Share, by Manufacturer (2021&2022)
-
Figure Global and China NK Cells Market Share, by Manufacturer in 2021
-
Figure Global and China NK Cells Market Share, by Manufacturer in 2022
-
Table Global NK Cells Sales Volume, by Type (2017-2028)
-
Table Global NK Cells Sales Volume Share, by Type (2017-2028)
-
Figure Global NK Cells Sales Volume Share, by Type (2017-2028)
-
Table Global NK Cells Sales Value, by Type (2017-2028)
-
Table Global NK Cells Sales Value Share, by Type (2017-2028)
-
Figure Global NK Cells Price Trend, by Type (2017-2028)
-
Table China NK Cells Sales Volume, by Type (2017-2028)
-
Table China NK Cells Sales Volume Share, by Type (2017-2028)
-
Figure China NK Cells Sales Volume Share, by Type (2017-2028)
-
Table China NK Cells Sales Value, by Type (2017-2028)
-
Table China NK Cells Sales Value Share, by Type (2017-2028)
-
Figure China NK Cells Price Trend, by Type (2017-2028)
-
Table Global NK Cells Sales Volume, by Application (2017-2028)
-
Table Global NK Cells Sales Volume Share, by Application (2017-2028)
-
Figure Global NK Cells Sales Volume Share, by Application (2017-2028)
-
Table Global NK Cells Sales Value, by Application (2017-2028)
-
Table Global NK Cells Sales Value Share, by Application (2017-2028)
-
Figure Global NK Cells Sales Value Share, by Application (2017-2028)
-
Table China NK Cells Sales Volume, by Application (2017-2028)
-
Table China NK Cells Sales Volume Share, by Application (2017-2028)
-
Figure China NK Cells Sales Volume Share, by Application (2017-2028)
-
Table China NK Cells Sales Value, by Application (2017-2028)
-
Table China NK Cells Sales Value Share, by Application (2017-2028)
-
Figure China NK Cells Sales Value Share, by Application (2017-2028)
-
Figure China NK Cells Production, Import, Consumption and Export (2017-2022)
-
Figure North America NK Cells Production, Import, Consumption and Export (2017-2022)
-
Figure Europe NK Cells Production, Import, Consumption and Export (2017-2022)
-
Figure APAC NK Cells Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa NK Cells Production, Import, Consumption and Export (2017-2022)
-
Table North America NK Cells Sales Volume, by Type (2017-2028)
-
Table North America NK Cells Sales Volume Share, by Type (2017-2028)
-
Figure North America NK Cells Sales Volume Share, by Type (2017-2028)
-
Table North America NK Cells Sales Volume, by Application (2017-2028)
-
Table North America NK Cells Sales Volume Share, by Application (2017-2028)
-
Figure North America NK Cells Sales Volume Share, by Application (2017-2028)
-
Figure United States NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure United States NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Canada NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Canada NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Mexico NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico NK Cells Sales Value and Growth Rate (2017-2028)
-
Table Europe NK Cells Sales Volume, by Type (2017-2028)
-
Table Europe NK Cells Sales Volume Share, by Type (2017-2028)
-
Figure Europe NK Cells Sales Volume Share, by Type (2017-2028)
-
Table Europe NK Cells Sales Volume, by Application (2017-2028)
-
Table Europe NK Cells Sales Volume Share, by Application (2017-2028)
-
Figure Europe NK Cells Sales Volume Share, by Application (2017-2028)
-
Figure Germany NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Germany NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure UK NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure UK NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure France NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure France NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Italy NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Italy NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Spain NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Spain NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Belgium NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Poland NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Poland NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Russia NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Russia NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Turkey NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey NK Cells Sales Value and Growth Rate (2017-2028)
-
Table APAC NK Cells Sales Volume, by Type (2017-2028)
-
Table APAC NK Cells Sales Volume Share, by Type (2017-2028)
-
Figure APAC NK Cells Sales Volume Share, by Type (2017-2028)
-
Table APAC NK Cells Sales Volume, by Application (2017-2028)
-
Table APAC NK Cells Sales Volume Share, by Application (2017-2028)
-
Figure APAC NK Cells Sales Volume Share, by Application (2017-2028)
-
Figure China NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure China NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Japan NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Japan NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure India NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure India NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure South Korea NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea NK Cells Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa NK Cells Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa NK Cells Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa NK Cells Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa NK Cells Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa NK Cells Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa NK Cells Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Brazil NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure South Africa NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa NK Cells Sales Value and Growth Rate (2017-2028)
-
Figure Argentina NK Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina NK Cells Sales Value and Growth Rate (2017-2028)
-
Table Affimed NV (Netherlands) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Affimed NV (Netherlands) Product Profiles, Application and Specification
-
Table Affimed NV (Netherlands) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table NantKwest Inc (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table NantKwest Inc (USA) Product Profiles, Application and Specification
-
Table NantKwest Inc (USA) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb (USA) Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb (USA) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Chipscreen Biosciences (China) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Chipscreen Biosciences (China) Product Profiles, Application and Specification
-
Table Chipscreen Biosciences (China) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sorrento Therapeutics Inc (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sorrento Therapeutics Inc (USA) Product Profiles, Application and Specification
-
Table Sorrento Therapeutics Inc (USA) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Takeda Pharmaceutical (Japan) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Takeda Pharmaceutical (Japan) Product Profiles, Application and Specification
-
Table Takeda Pharmaceutical (Japan) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Altor BioScience Corporation (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Altor BioScience Corporation (USA) Product Profiles, Application and Specification
-
Table Altor BioScience Corporation (USA) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Innate Pharma SA (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Innate Pharma SA (France) Product Profiles, Application and Specification
-
Table Innate Pharma SA (France) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table NKT Therapeutics (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table NKT Therapeutics (USA) Product Profiles, Application and Specification
-
Table NKT Therapeutics (USA) NK Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
